157 related articles for article (PubMed ID: 37695304)
21. [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].
Wang X; Zhao C; Li H; Chen H; Jin L; Wang Z; Liao K; Zeng J; Xu X; Jin Y; Su D; Liu W; Hu Z; Cao B; Chu Y; Zhang R; Luo Y; Hu B; Wang H
Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1205-1217. PubMed ID: 30152206
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of In vitro Efficacy of Meropenem/Colistin and Meropenem/Fosfomycin Combinations on Multidrug Resistant Gram-Negative Bacilli].
Adaleti R; Nakipoğlu Y; Arıcı N; Kansak N; Çalık Ş; Şenbayrak S; Balık R; Aksaray S
Mikrobiyol Bul; 2023 Jul; 57(3):365-377. PubMed ID: 37462301
[TBL] [Abstract][Full Text] [Related]
23. Colistin resistance mechanisms in Gram-negative bacteria: a Focus on Escherichia coli.
Abavisani M; Bostanghadiri N; Ghahramanpour H; Kodori M; Akrami F; Fathizadeh H; Hashemi A; Rastegari-Pouyani M
Lett Appl Microbiol; 2023 Feb; 76(2):. PubMed ID: 36754367
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of novel rifamycin derivatives against rifamycin-sensitive and -resistant Staphylococcus aureus isolates in murine models of infection.
Rothstein DM; Farquhar RS; Sirokman K; Sondergaard KL; Hazlett C; Doye AA; Gwathmey JK; Mullin S; van Duzer J; Murphy CK
Antimicrob Agents Chemother; 2006 Nov; 50(11):3658-64. PubMed ID: 16940074
[TBL] [Abstract][Full Text] [Related]
25. Synergistic effect of antimicrobial peptide LL-37 and colistin combination against multidrug-resistant
Morroni G; Sante LD; Simonetti O; Brescini L; Kamysz W; Kamysz E; Mingoia M; Brenciani A; Giovanetti E; Bagnarelli P; Giacometti A; Cirioni O
Future Microbiol; 2021 Mar; 16():221-227. PubMed ID: 33646013
[No Abstract] [Full Text] [Related]
26. Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection models.
Patel MV; De Souza NJ; Gupte SV; Jafri MA; Bhagwat SS; Chugh Y; Khorakiwala HF; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2004 Dec; 48(12):4754-61. PubMed ID: 15561853
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of ceftaroline, ceftazidime-avibactam, and comparators against Gram-positive and -negative organisms in China: the 2018 results from the ATLAS program.
Jia P; Zhu Y; Zhang H; Cheng B; Guo P; Xu Y; Yang Q
BMC Microbiol; 2022 Oct; 22(1):234. PubMed ID: 36182895
[TBL] [Abstract][Full Text] [Related]
28. Activities of fosfomycin, tigecycline, colistin, and gentamicin against extended-spectrum-β-lactamase-producing Escherichia coli in a foreign-body infection model.
Corvec S; Furustrand Tafin U; Betrisey B; Borens O; Trampuz A
Antimicrob Agents Chemother; 2013 Mar; 57(3):1421-7. PubMed ID: 23295934
[TBL] [Abstract][Full Text] [Related]
29. Occurrence and Characteristics of
Wu L; Xu T; Ji Y; Song J; Wang F; Huang J; Zhou K
Microbiol Spectr; 2022 Feb; 10(1):e0193821. PubMed ID: 35138190
[TBL] [Abstract][Full Text] [Related]
30. Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria
Zhang Y; Lin Y; Zhang X; Chen L; Xu C; Liu S; Cao J; Zheng X; Jia H; Chen L; Zhou T
Microbiol Spectr; 2021 Dec; 9(3):e0123121. PubMed ID: 34730415
[TBL] [Abstract][Full Text] [Related]
31. Thymol Increases Sensitivity of Clinical Col-R Gram-Negative Bacteria to Colistin.
Yao Z; Feng L; Zhao Y; Zhang X; Chen L; Wang L; Zhang Y; Sun Y; Zhou T; Cao J
Microbiol Spectr; 2022 Aug; 10(4):e0018422. PubMed ID: 35700133
[TBL] [Abstract][Full Text] [Related]
32. Protection with antibody to tumor necrosis factor differs with similarly lethal Escherichia coli versus Staphylococcus aureus pneumonia in rats.
Karzai W; Cui X; Mehlhorn B; Straube E; Hartung T; Gerstenberger E; Banks SM; Natanson C; Reinhart K; Eichacker PQ
Anesthesiology; 2003 Jul; 99(1):81-9. PubMed ID: 12826846
[TBL] [Abstract][Full Text] [Related]
33. Gram-Positive and Gram-Negative Antibiotic Activity of Asymmetric and Monomeric Robenidine Analogues.
Russell CC; Stevens A; Pi H; Khazandi M; Ogunniyi AD; Young KA; Baker JR; McCluskey SN; Page SW; Trott DJ; McCluskey A
ChemMedChem; 2018 Dec; 13(23):2573-2580. PubMed ID: 30318716
[TBL] [Abstract][Full Text] [Related]
34. Erythropoietin Promotes Infection Resolution and Lowers Antibiotic Requirements in
Liang F; Guan H; Li W; Zhang X; Liu T; Liu Y; Mei J; Jiang C; Zhang F; Luo B; Zhang Z
Front Immunol; 2021; 12():658715. PubMed ID: 33927725
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models.
Parra Millán R; Jiménez Mejías ME; Sánchez Encinales V; Ayerbe Algaba R; Gutiérrez Valencia A; Pachón Ibáñez ME; Díaz C; Pérez Del Palacio J; López Cortés LF; Pachón J; Smani Y
Antimicrob Agents Chemother; 2016 Aug; 60(8):4464-70. PubMed ID: 27161639
[TBL] [Abstract][Full Text] [Related]
36. Reversible antibiotic tolerance induced in Staphylococcus aureus by concurrent drug exposure.
Haaber J; Friberg C; McCreary M; Lin R; Cohen SN; Ingmer H
mBio; 2015 Jan; 6(1):. PubMed ID: 25587013
[TBL] [Abstract][Full Text] [Related]
37. Colistin- and Carbapenem-Resistant Escherichia coli Harboring mcr-1 and blaNDM-5, Causing a Complicated Urinary Tract Infection in a Patient from the United States.
Mediavilla JR; Patrawalla A; Chen L; Chavda KD; Mathema B; Vinnard C; Dever LL; Kreiswirth BN
mBio; 2016 Aug; 7(4):. PubMed ID: 27578755
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).
Petersen PJ; Jacobus NV; Weiss WJ; Sum PE; Testa RT
Antimicrob Agents Chemother; 1999 Apr; 43(4):738-44. PubMed ID: 10103174
[TBL] [Abstract][Full Text] [Related]
39. Azidothymidine Produces Synergistic Activity in Combination with Colistin against Antibiotic-Resistant
Hu Y; Liu Y; Coates A
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373798
[TBL] [Abstract][Full Text] [Related]
40. Liposomes Co-Delivering Curcumin and Colistin to Overcome Colistin Resistance in Bacterial Infections.
Qin C; Tang N; Gan Y; Zhao H; Li Y; Tian GB; Yang YY; Yuan P; Ding X
Adv Healthc Mater; 2023 Sep; 12(24):e2202903. PubMed ID: 37523195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
